Cargando…

Imidazoline-I2 PET Tracers in Neuroimaging

Targeting neuroinflammation, and in particular, microglial activation and astrocytosis, is a current area of the focus of new treatment interventions for a number of neurodegenerative disorders. Probing the roles of microglia and astrocytes in human disease requires the development of useful tools,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parker, Christine A., Nutt, David J., Tyacke, Robin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298009/ https://www.ncbi.nlm.nih.gov/pubmed/37372936 http://dx.doi.org/10.3390/ijms24129787

Ejemplares similares

First evaluation of PET-based human biodistribution and radiation dosimetry of (11)C-BU99008, a tracer for imaging the imidazoline(2) binding site
por: Venkataraman, Ashwin V., et al.
Publicado: (2018)

Identification of an imidazoline binding protein: Creatine kinase and an imidazoline-2 binding site
por: Kimura, Atsuko, et al.
Publicado: (2009)

The influence of different cellular environments on PET radioligand binding: An application to D(2/3)-dopamine receptor imaging
por: Quelch, Darren R., et al.
Publicado: (2014)

2-Imidazoline Nitroxide Derivatives of Cymantrene
por: Maryunina, Kseniya, et al.
Publicado: (2022)

PET Tracers for Clinical Imaging of Breast Cancer
por: Peñuelas, Iván, et al.
Publicado: (2012)

Functional Alternatives to Alcohol
por: Nutt, David J., et al.
Publicado: (2022)

Emerging PET Tracers in Cardiac Molecular Imaging
por: Singh, Shashi Bhushan, et al.
Publicado: (2023)

Potential PET tracers for imaging of tumor-associated macrophages
por: Fernandes, Bruna, et al.
Publicado: (2022)

Conceptual Model for Using Imidazoline Derivative Solutions in Pulpal Management
por: Jones, Robert S.
Publicado: (2021)

The imidazoline receptors and ligands in pain modulation
por: Bektas, Nurcan, et al.
Publicado: (2015)

Methodology for Quantitative Rapid Multi-Tracer PET Tumor Characterizations
por: Kadrmas, Dan J., et al.
Publicado: (2013)

Microfluidics for Synthesis of Peptide-Based PET Tracers
por: Liu, Yang, et al.
Publicado: (2013)

Advanced Tracers in PET Imaging of Cardiovascular Disease
por: Li, Yesen, et al.
Publicado: (2014)

Microfluidics: A Groundbreaking Technology for PET Tracer Production?
por: Rensch, Christian, et al.
Publicado: (2013)

Update on PET Tracer Development for Muscarinic Acetylcholine Receptors
por: Ozenil, Marius, et al.
Publicado: (2021)

Breast PET/MRI Hybrid Imaging and Targeted Tracers
por: Romeo, Valeria, et al.
Publicado: (2022)

PET Imaging in Cardiac Sarcoidosis: A Narrative Review with Focus on Novel PET Tracers
por: Saric, Petar, et al.
Publicado: (2021)

Discriminative stimulus effects of the novel imidazoline I(2) receptor ligand CR4056 in rats
por: Qiu, Yanyan, et al.
Publicado: (2014)

Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts
por: Korat, Špela, et al.
Publicado: (2021)

Insights into the Pharmacokinetics and In Vitro Cell-Based Studies of the Imidazoline I(2) Receptor Ligand B06
por: Bagán, Andrea, et al.
Publicado: (2022)

Translating Molecules into Imaging—The Development of New PET Tracers for Patients with Melanoma
por: Vercellino, Laetitia, et al.
Publicado: (2022)

Application of PET Tracers in Molecular Imaging for Breast Cancer
por: Boers, Jorianne, et al.
Publicado: (2020)

Imaging with non-FDG PET tracers: outlook for current clinical applications
por: Lopci, Egesta, et al.
Publicado: (2010)

Beyond FDG: novel PET tracers for cancer imaging
por: Hicks, Rodney J
Publicado: (2003)

I(1) Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline
por: Barac, Yaron D., et al.
Publicado: (2012)

Novel I(1)-Imidazoline Agonist S43126 Augment Insulin Secretion in Min6 Cells
por: Tesfai, Jerusalem, et al.
Publicado: (2012)

Modulation of imidazoline I(2) binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats
por: Lanza, Marco, et al.
Publicado: (2014)

PET tracer development—a tale of mice and men
por: Hicks, Rodney J, et al.
Publicado: (2006)

State of the art procedures towards reactive [(18)F]fluoride in PET tracer synthesis
por: Haveman, Lizeth Y. F., et al.
Publicado: (2023)

Stroke detection with 3 different PET tracers
por: Dundar, Ayca, et al.
Publicado: (2019)

Palladium-Catalyzed Multicomponent Synthesis of 2-Imidazolines from Imines and Acid Chlorides
por: Xu, Boran, et al.
Publicado: (2012)

Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications
por: Visser, Anniek K. D., et al.
Publicado: (2010)

The development and validation of tau PET tracers: current status and future directions
por: Okamura, Nobuyuki, et al.
Publicado: (2018)

Protocols for Dual Tracer PET/SPECT Preclinical Imaging
por: Blower, Julia E., et al.
Publicado: (2020)

The Sensitivity of Tau Tracers for the Discrimination of Alzheimer’s Disease Patients and Healthy Controls by PET
por: Mohammadi, Zohreh, et al.
Publicado: (2023)

Recent developments on PET radiotracers for TSPO and their applications in neuroimaging
por: Zhang, Lingling, et al.
Publicado: (2021)

Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors
por: Helgebostad, Rasmus, et al.
Publicado: (2022)

Rilmenidine extends lifespan and healthspan in Caenorhabditis elegans via a nischarin I1‐imidazoline receptor
por: Bennett, Dominic F., et al.
Publicado: (2023)

Correction: I(1) Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline
por: Barac, Yaron D., et al.
Publicado: (2013)

Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands
por: Zhou, Zhicheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jkg8hnsotedvbsrsqt5qvf1v93